Abbott Cuts Kaletra Price In 40 Countries
This article was originally published in The Pink Sheet Daily
Executive Summary
Move follows spat between firm and Thailand over country’s decision to allow generic HIV therapies.
You may also be interested in...
Abbott Low Dose Kaletra Tablet Clears FDA For Pediatric HIV Patients
Lower strength tablet formulation will be available at half the cost of full strength tablet in developing countries, according to Abbott.
Abbott Low Dose Kaletra Tablet Clears FDA For Pediatric HIV Patients
Lower strength tablet formulation will be available at half the cost of full strength tablet in developing countries, according to Abbott.
Abbott To File In Thailand For Kaletra Pediatric AIDS Indication
In an apparent change of position, Abbott will file for approval of a pediatric formulation of its antiretroviral protease inhibitor Kaletra (lopinavir/ritonavir) tablets in Thailand, the firm announced July 27